Author

Fiorella Cañete

MORBID OBESITY, A NEW SUSCEPTIBILITY FACTOR FOR DEVELOPING INFLAMMATORY BOWEL DISEASE. RESULTS OF A POPULATION-BASED STUDY
MORBID OBESITY, A NEW SUSCEPTIBILITY FACTOR FOR DEVELOPING INFLAMMATORY BOWEL DISEASE. RESULTS OF A POPULATION-BASED STUDY

Fiorella Cañete  et al.

MORBID OBESITY, A NEW SUSCEPTIBILITY FACTOR FOR DEVELOPING INFLAMMATORY BOWEL DISEASE. RESULTS OF A POPULATION-BASED STUDY
MORBID OBESITY, A NEW SUSCEPTIBILITY FACTOR FOR DEVELOPING INFLAMMATORY BOWEL DISEASE. RESULTS OF A POPULATION-BASED STUDY

COMBINATION OF GRANULOCYTE–MONOCYTE APHERESIS AND TOFACITINIB: MULTICENTRE AND RETROSPECTIVE STUDY
COMBINATION OF GRANULOCYTE–MONOCYTE APHERESIS AND TOFACITINIB: MULTICENTRE AND RETROSPECTIVE STUDY

Fiorella Cañete  et al.

CAN HOSPITAL ADMISSIONS FOR LOWER GASTROINTESTINAL BLEEDING BE REDUCED? IMPLEMENTATION OF TWO SCALES FOR THE PREDICTION OF SAFETY DISCHARGE IN A RETROSPECTIVE COHORT
CAN HOSPITAL ADMISSIONS FOR LOWER GASTROINTESTINAL BLEEDING BE REDUCED? IMPLEMENTATION OF TWO SCALES FOR THE PREDICTION OF SAFETY DISCHARGE IN A RETROSPECTIVE COHORT

Fiorella Cañete  et al.

MANAGEMENT AND OUTCOMES OF LOWER GASTROINTESTINAL BLEEDING IN PATIENTS ON ANTICOAGULATION
MANAGEMENT AND OUTCOMES OF LOWER GASTROINTESTINAL BLEEDING IN PATIENTS ON ANTICOAGULATION

Fiorella Cañete  et al.

LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU
LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU

Fiorella Cañete  et al.

CHARACTERIZATION OF THE FATTY ACID PROFILE OF THE CREEPING FAT OF CROHN’S DISEASE IN COMPARISON TO INFLAMMATORY BOWEL DISEASE-FREE CONTROLS
CHARACTERIZATION OF THE FATTY ACID PROFILE OF THE CREEPING FAT OF CROHN’S DISEASE IN COMPARISON TO INFLAMMATORY BOWEL DISEASE-FREE CONTROLS

Fiorella Cañete  et al.

HIGHER PERFORMANCE OF FAECAL MICROBIAL MARKERS TO MONITOR ENDOSCOPIC ACTIVITY IN CROHN’S DISEASE, AS COMPARED TO FAECAL CALPROTECTIN
HIGHER PERFORMANCE OF FAECAL MICROBIAL MARKERS TO MONITOR ENDOSCOPIC ACTIVITY IN CROHN’S DISEASE, AS COMPARED TO FAECAL CALPROTECTIN

Fiorella Cañete  et al.

SAFETY OF INFLAMMATORY BOWEL DISEASE TREATMENTS IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION (EITOS STUDY OF GETECCU)
SAFETY OF INFLAMMATORY BOWEL DISEASE TREATMENTS IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION (EITOS STUDY OF GETECCU)

Fiorella Cañete  et al.

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB THERAPY FOR COMPLEX PERIANAL FISTULA IN CROHN’S DISEASE: THE HEAL STUDY
EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB THERAPY FOR COMPLEX PERIANAL FISTULA IN CROHN’S DISEASE: THE HEAL STUDY

Fiorella Cañete  et al.

USTEKINUMAB AND VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY
USTEKINUMAB AND VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE IN CLINICAL PRACTICE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY

Fiorella Cañete  et al.

EFFECTIVENESS AND SAFETY OF SWITCHING FROM ADALIMUMAB REFERENCE TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: THE ADA-SWITCH STUDY
EFFECTIVENESS AND SAFETY OF SWITCHING FROM ADALIMUMAB REFERENCE TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: THE ADA-SWITCH STUDY

Fiorella Cañete  et al.

MANAGEMENT AND OUTCOME OF POSTOPERATIVE CROHN’S DISEASE IN THE ELDERLY AS COMPARED TO YOUNG ADULTS: DATA FROM ENEIDA REGISTRY
MANAGEMENT AND OUTCOME OF POSTOPERATIVE CROHN’S DISEASE IN THE ELDERLY AS COMPARED TO YOUNG ADULTS: DATA FROM ENEIDA REGISTRY

Fiorella Cañete  et al.

HIV INFECTION IS ASSOCIATED WITH A LESS AGGRESSIVE PHENOTYPE OF INFLAMMATORY BOWEL DISEASE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY
HIV INFECTION IS ASSOCIATED WITH A LESS AGGRESSIVE PHENOTYPE OF INFLAMMATORY BOWEL DISEASE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY

Fiorella Cañete  et al.

Item 1 - 14 / 14
1